APA (7th ed.) Citation

JJG, M., M, A., L, Á., N, H., K, D., RP, M., . . . M, R. (2026). Impact of CD44 alternative splicing on the response to anticancer drugs. Biochemical pharmacology, 251(Pt 1), 118111. https://doi.org/10.1016/j.bcp.2026.118111

Chicago Style (17th ed.) Citation

JJG, Marin, et al. "Impact of CD44 Alternative Splicing on the Response to Anticancer Drugs." Biochemical Pharmacology 251, no. Pt 1 (2026): 118111. https://doi.org/10.1016/j.bcp.2026.118111.

MLA (9th ed.) Citation

JJG, Marin, et al. "Impact of CD44 Alternative Splicing on the Response to Anticancer Drugs." Biochemical Pharmacology, vol. 251, no. Pt 1, 2026, p. 118111, https://doi.org/10.1016/j.bcp.2026.118111.